Terra Innovatum Global N.V. (NKLR) Q4 2025 earnings summary

Executive summary

• Achieved major milestones in 2025, including regulatory progress, supply chain security, and $4B in pre-commercial commitments for micro-modular reactors targeting deployment in 2028.

• Completed first annual reporting cycle as a public company, establishing internal reporting precedents.

• Reactor design finalized, supply chain secured, and manufacturing strategy defined for factory-based deployment.

• Built a robust commercial pipeline with non-binding MOUs for up to 200 SOLO units across multiple sectors.

• Selected Rock City Admiral Parkway in Illinois as the FOAK deployment site, with an option for up to 50 commercial SOLO units.

Financial highlights

• Ended FY2025 with $102.9 million in cash and no debt, fully funding expected licensing and construction activities.

• Net income for 2025 was $539.5 million, or $9.74 per diluted share, primarily due to non-cash unrealized gains.

• Loss from operations for 2025 was $33.7 million, reflecting increased investment in licensing and engineering.

• $4B in pre-commercial commitments based on non-binding MOUs for up to 200 SOLO units at $19M per unit.

• No revenue generated from the SOLO program to date; expects continued operating losses as commercialization advances.

Outlook and guidance

• FOAK deployment targeted for 2027, with commercialization and broader deployment in 2028.

• Plans to submit the Safety Analysis Report to the NRC by mid-2026, supporting NRC approval and initial commercial operations.

• No further R&D required for FOAK; current cash expected to fully fund FOAK.

• Expanding commercial pipeline and advancing customer orders for SOLO reactors.

• Anticipates SOLO will be available globally within three years, targeting commercialization in 2028.